Cite
MLA Citation
M Cardenas et al.. “CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice.” European journal of hospital pharmacy, vol. 22, n.d., p. A24. http://access.bl.uk/ark:/81055/vdc_100172521815.0x00001a